I8F-MC-GPHM - ClinicalTrials.gov - NCT04657016
I8F-MC-GPHM - ClinicalTrials.gov - NCT04657016
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have a body mass index (BMI) ≥30 kg/m2 or ≥27 kg/m2
Participants must be previously diagnosed with at least 1 of the following High blood pressure, high cholesterol, Sleep Apnea or Heart disease
Participants must NOT
Participants must not have type 1 diabetes or type 2 diabetes
Participant must not have been taking weight loss drugs, including over-the-counter medications during the last 3 months
Participants must not have had a heart attack, stroke, or hospitalization for congestive heart failure in the past 2 months
Participants must not have pancreatitis
Participants must not have a personal or family history of medullary thyroid carcinoma or personal history of multiple endocrine neoplasia syndrome type 2
Trial Summary
Conditions the trial is for
Overweight, Very Overweight
What the trial is testing?
Tirzepatide
Could I receive a Placebo?
yes
Enrollment Goal
800
Trial Dates
April 2021 - September 2023
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have a body mass index (BMI) ≥30 kg/m2 or ≥27 kg/m2
Participants must be previously diagnosed with at least 1 of the following High blood pressure, high cholesterol, Sleep Apnea or Heart disease
Participants must NOT
Participants must not have type 1 diabetes or type 2 diabetes
Participant must not have been taking weight loss drugs, including over-the-counter medications during the last 3 months
Participants must not have had a heart attack, stroke, or hospitalization for congestive heart failure in the past 2 months
Participants must not have pancreatitis
Participants must not have a personal or family history of medullary thyroid carcinoma or personal history of multiple endocrine neoplasia syndrome type 2
Trial Summary
Conditions the trial is for
Overweight, Very Overweight
What the trial is testing?
Tirzepatide
Could I receive a Placebo?
yes
Enrollment Goal
800
Trial Dates
April 2021 - September 2023
Trial Phase
3
Trial Locations
Hide locations not currently recruiting